Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UK Multicentre Open-label Randomised Controlled Trial Of IV Iron Therapy
2013-002267-25Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of iron sucrose in anemia of chronic kidney disease, end-stage kidney disease (ESKD) and iron deficiency anemia (IDA) (2 arms), sponsored by King's College Hospital. Primary endpoint: Time to all-cause death or composite non-fatal cardiovascular events. Started Jul 2013; status: completed.
02
Drugs
iron sucrose
03
Conditions
anemia of chronic kidney diseaseend-stage kidney disease (ESKD)iron deficiency anemia (IDA)
Beyond the preview
Go deeper on 2013-002267-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002267-25.